Keywords: alnylam, acquires, systemic, sirna, delivery, ip, rna

Alnylam acquires systemic siRNA delivery IP

Article | 15 May 2006

US RNA interference specialist Alnylam Pharmaceuticals has obtained rights to RNAi delivery technology developed at Harvard University's CBR Institute for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Alnylam Pharmaceuticals

Go to company listing